48
Participants
Start Date
September 21, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
December 31, 2025
JMKX000189
JMKX000189 will be administered orally once a day
Placebo
Placebo will be administered orally once a day
NOT_YET_RECRUITING
Xuanwu Hospital, Capital Medical University, Beijing
RECRUITING
Peking Union Medical College Hospital, Beijing
NOT_YET_RECRUITING
China-Japan Union Hospital of Jilin University, Changchun
NOT_YET_RECRUITING
Huashan Hospital Affiliated to Fudan University, Shanghai
NOT_YET_RECRUITING
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
NOT_YET_RECRUITING
Jiangsu Province Hospital, Nanjing
NOT_YET_RECRUITING
The First Affiliated Hospital of Bengbu Medical College, Bengbu
NOT_YET_RECRUITING
Qilu Hospital of Shandong University, Jinan
NOT_YET_RECRUITING
Binzhou Medical University Hospital, Binzhou
NOT_YET_RECRUITING
Jining First People's Hospital, Jining
NOT_YET_RECRUITING
Pingxiang People's Hospital, Pingxiang
NOT_YET_RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Xinxiang Central Hospital, Xinxiang
NOT_YET_RECRUITING
The First Affiliated Hospital of Henan University of science and Technology, Luoyang
NOT_YET_RECRUITING
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
NOT_YET_RECRUITING
West China Hospital Sichuan University, Chengdu
NOT_YET_RECRUITING
Shanxi Bethune Hospital, Taiyuan
Lead Sponsor
Jemincare
INDUSTRY